CIBRA Capital’s Amedisys AMED Stock Holding History

CIBRA Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$20.1M	Buy	216,775 +169,616	+360%	+$15.6M	6.86%	7
2024 Q4	$4.28M	Buy	+47,159	New	+$4.33M	2.92%	11

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

CIBRA Capital's AMED Position: Q1 2025 in Review

CIBRA Capital increased its Amedisys (AMED) stake by 360% in Q1 2025, buying an estimated $15.6M and bringing the position to 216,775 shares worth $20.1M. The position accounts for 6.86% of the portfolio, ranked #7.

CIBRA Capital first reported a position in AMED in Q4 2024 and has held it in 2 quarters since. 305 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

CIBRA Capital held 216,775 shares of Amedisys worth $20.1M as of Q1 2025.
CIBRA Capital bought 169,616 Amedisys shares in Q1 2025, an estimated $15.6M.
Amedisys made up 6.86% of CIBRA Capital's portfolio in Q1 2025, its #7 holding.
CIBRA Capital first reported a position in Amedisys in Q4 2024 and has held it in 2 quarters since.
305 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on CIBRA Capital's 13F filing for Q1 2025, filed 28 Apr 2025.